NanoArrayer™ a Key Element in Harvard Research Project
News Apr 20, 2006
BioForce Nanosciences has received a letter of intent to purchase a NanoArrayer™ System from the Technology & Engineering Center at the Harvard Medical School (HMS).
Funding for the purchase will come from a National Human Genome Research Institute (NHGRI) award with purchase and installation of the technology expected later this summer.
Dale Larson, principal investigator on this project, is the Director of the Technology and Engineering Center (TEC) at HMS.
In the letter of intent Larson noted, "Our nanohole array sensors can be made as small as 0.050 micron x 1.050 micron and as far as I know your technology is the only commercially available method to print such small areas."
"In the genomics and proteomics fields as samples continue to shrink in size and sample numbers continue to increase, these smaller sensor platforms become critical."
Michael Lynch, Product Manager for the NanoArrayer™ System coordinated closely with Larson in the grant submission process for obtaining funding for the instrument.
"We are very excited about this placement. Using the NanoArrayer System to activate or functionalize these very small biosensors is a key application for this technology."
"As sensor detection platforms reduce in size, it becomes a challenge to print a variety of detector molecules on such a small surface area. The NanoArrayer™ System is designed to meet this market need."
Dr. Eric Henderson, Founder and CEO of BioForce Nanosciences, commented, "We are pleased to see firm plans for the sale of a NanoArrayer™System to this prestigious institution."
"The groundbreaking work performed at Harvard will provide validation of the value that this enabling technology provides to biosensor technology development. We look forward to working with Dale and his group."
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Nano-tech Diagnostic Can Indicate Cancer or Thrombotic Risk in One Drop of BloodNews
A team of international researchers led by Professor Martin Hegner, Investigator in CRANN and Trinity’s School of Physics, have developed an automated diagnostic platform that can quantify bleeding – and thrombotic risks – in a single drop of blood, within seconds.READ MORE
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE